levodopa has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labruyere, J; Olney, JW; Price, MT; Stewart, GR; Wang, GJ; Zorumski, CF | 1 |
| Itakura, T; Nakai, K; Nakao, N | 1 |
2 other study(ies) available for levodopa and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Chick Embryo; Dibenzocycloheptenes; Dihydroxyphenylalanine; Dizocilpine Maleate; Hippocampus; Huntington Disease; Levodopa; Neurons; Parkinson Disease; Quinoxalines; Receptors, Neurotransmitter; Retina | 1990 |
Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Antioxidants; Cells, Cultured; Dizocilpine Maleate; Dopamine; Dopamine Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Levodopa; Mesencephalon; NAD(P)H Dehydrogenase (Quinone); Neurons; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Uncoupling Agents | 1997 |